Spectral AI, Inc. (MDAI)
NASDAQ: MDAI · Real-Time Price · USD
1.560
-0.050 (-3.11%)
At close: Jan 16, 2026, 4:00 PM EST
1.590
+0.030 (1.92%)
After-hours: Jan 16, 2026, 7:29 PM EST
Spectral AI Market Cap
Spectral AI has a market cap or net worth of $47.87 million as of January 16, 2026. Its market cap has decreased by -27.08% in one year.
Market Cap
47.87M
Enterprise Value
47.04M
1-Year Change
-27.08%
Ranking
Category
Stock Price
$1.56
Market Cap Chart
Since April 6, 2021, Spectral AI's market cap has decreased from $298.76M to $47.87M, a decrease of -83.98%. That is a compound annual growth rate of -31.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 15, 2026 | 49.41M | 13.38% |
| Dec 31, 2025 | 43.58M | -28.46% |
| Dec 31, 2024 | 60.91M | 51.96% |
| Dec 29, 2023 | 40.09M | -87.45% |
| Dec 30, 2022 | 319.41M | 2.96% |
| Dec 31, 2021 | 310.24M | 3.84% |
| Apr 6, 2021 | 298.76M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 961.00B |
| Johnson & Johnson | 526.55B |
| AbbVie | 392.16B |
| UnitedHealth Group | 303.42B |
| AstraZeneca | 299.25B |
| Novartis AG | 278.73B |
| Merck & Co. | 275.53B |
| Novo Nordisk | 262.20B |